Vir Biotechnology, Inc.
SEC 4 · Filed
0001628280-26-012396Accepted
Applies to the EDGAR acceptance time.
Other time zone
Insider transactionsEvent date Feb 24, 2026
- Security
- Common Stock
- Shares
-
1,430
- Price per share
-
9.53
Reported 9.5326
Structured facts
{
"code": "S",
"date": "2026-02-24",
"direction": "D",
"exercise_price": null,
"expiration": null,
"footnotes": {
"F1": "Represents an automatic and mandatory sale of shares under a Rule 10b5-1 arrangement to satisfy the Issuer\u0027s tax withholding obligations in connection with the vesting of restricted stock units. The sale does not represent a discretionary trade by the Reporting Person."
},
"owners": [
{
"cik": "0002037272",
"name": "Sabatini Brent",
"roles": [
"officer"
],
"title": "SVP, Chief Accounting Officer"
}
],
"ownership": "D",
"post_shares": "69613",
"price": "9.5326",
"row": 1,
"rule_10b5_1": "1",
"security": "Common Stock",
"shares": "1430",
"table": "I",
"underlying_security": null,
"underlying_shares": null
}